دورية أكاديمية

ACTR-46. AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS

التفاصيل البيبلوغرافية
العنوان: ACTR-46. AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS
المؤلفون: Mellinghoff, Ingo K., Touat, Mehdi, Maher, Elizabeth, DeLaFuente, Macarena, Cloughesy, Timothy F., Holdhoff, Matthias, Cote, Gregory, Burris, Howard, Janku, Filip, Huang, Raymond, Young, Robert, Ellingson, Benjamin, Auer, Julia, Liu, Hua, Hurov, Jonathan, Yen, Katherine, Agresta, Sam, Attar, Eyal, Pandya, Susan, Wen, Patrick Y.
المصدر: Neuro-Oncology ; volume 18, issue suppl_6, page vi12-vi12 ; ISSN 1522-8517 1523-5866
بيانات النشر: Oxford University Press (OUP)
سنة النشر: 2016
مصطلحات موضوعية: Cancer Research, Neurology (clinical), Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1093/neuonc/now212.044
الإتاحة: https://doi.org/10.1093/neuonc/now212.044Test
http://academic.oup.com/neuro-oncology/article-pdf/18/suppl_6/vi12/9645245/now212.044.pdfTest
رقم الانضمام: edsbas.225B8AB
قاعدة البيانات: BASE